dianhydrogalactitol has been researched along with mitolactol in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (92.31) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Olah, E; Palyi, I; Sugar, J | 1 |
Institoris, L; Jeney, A; Szende, B | 1 |
Andersen, J; Frei, E; Furlong, EA; Henner, WD; Kelley, SL; Peters, WP | 1 |
Csetényi, J; Eckhardt, S; Hegedüs, L; Horváth, IP; Kanyár, B; Kerpel-Fronius, S | 1 |
Eckhardt, S; Horváth, IP; Institoris, L; Kerpel-Fronius, S | 1 |
Kerpel-Fronius, S | 1 |
Edwards, MS; Fulton, D; Gutin, PH; Levin, VA; Seager, M; Vestnys, P; Wilson, CB | 1 |
Chiuten, DF; Muggia, FM; Rozencweig, M; Von Hoff, DD | 1 |
Hegedüs, L; Horváth, IP; Jarman, M; Somfai-Relle, S | 1 |
Hedegüs, L; Somfai-Relle, S; Sugár, J; Tóth, K | 1 |
Levin, VA; Wheeler, KT | 1 |
Gáti, E; Somfai-Relle, S | 1 |
Gáti, E; Holczinger, L; Institoris, E; Somfai-Relle, S; Turi, G | 1 |
2 review(s) available for dianhydrogalactitol and mitolactol
Article | Year |
---|---|
Hungarian anticancer drugs (antineoplastics).
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Dianhydrogalactitol; Erythritol; Humans; Kinetics; Mannomustine; Mesylates; Mitobronitol; Mitolactol; Rats | 1982 |
Clinical trials with the hexitol derivatives in the U.S.
Topics: Animals; Clinical Trials as Topic; Dianhydrogalactitol; Dogs; Humans; Kinetics; Mannitol; Mice; Mitobronitol; Mitolactol; Neoplasms; Sugar Alcohols | 1981 |
1 trial(s) available for dianhydrogalactitol and mitolactol
Article | Year |
---|---|
Clinical trials with the hexitol derivatives in the U.S.
Topics: Animals; Clinical Trials as Topic; Dianhydrogalactitol; Dogs; Humans; Kinetics; Mannitol; Mice; Mitobronitol; Mitolactol; Neoplasms; Sugar Alcohols | 1981 |
11 other study(ies) available for dianhydrogalactitol and mitolactol
Article | Year |
---|---|
Effects of cytostatics on proliferating and stationary cultures of mammalian cells.
Topics: Antineoplastic Agents; Bleomycin; Cell Cycle; Cell Division; Cell Survival; Cells, Cultured; Dianhydrogalactitol; Dose-Response Relationship, Drug; Mitolactol; Vinca Alkaloids; Vincristine | 1978 |
The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.
Topics: Administration, Intravesical; Administration, Oral; Animals; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Dianhydrogalactitol; Doxorubicin; Female; Mitolactol; Papilloma; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Urinary Bladder Neoplasms | 1992 |
Pharmacokinetics of dibromodulcitol in humans: a phase I study.
Topics: Absorption; Administration, Oral; Adult; Aged; Bone Marrow Transplantation; Carcinoma; Dianhydrogalactitol; Dose-Response Relationship, Drug; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Male; Melanoma; Middle Aged; Mitolactol; Neoplasm Metastasis; Sarcoma; Time Factors | 1986 |
Pharmacokinetics and metabolism of dianhydrogalactitol DAG in patients: a comparison with the human disposition of dibromodulcitol DBD.
Topics: Adult; Aged; Alkylation; Biotransformation; Dianhydrogalactitol; Female; Humans; Kinetics; Male; Middle Aged; Mitolactol; Models, Biological; Neoplasms; Pleural Effusion; Protein Binding; Sugar Alcohols | 1986 |
Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Dianhydrogalactitol; DNA Replication; Drug Evaluation; Female; Humans; Male; Mice; Mitolactol; Neoplasms; Neoplasms, Experimental; Structure-Activity Relationship; Sugar Alcohols | 1985 |
Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dianhydrogalactitol; Drug Evaluation; Ependymoma; Female; Glioma; Humans; Male; Medulloblastoma; Middle Aged; Mitolactol; Neoplasm Recurrence, Local | 1984 |
Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: a comparison with the related dibromo- and dianhydro-derivatives.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Dianhydrogalactitol; Lethal Dose 50; Leukopenia; Mannitol; Mice; Mitobronitol; Mitolactol; Rats | 1982 |
Mutagenicity of dibromodulcitol (DBD), an alkylating anticancer drug) and its mono- and bifunctional conversion products studied by the Salmonella/microsome assay.
Topics: Animals; Carcinogens; Cyclophosphamide; Dianhydrogalactitol; Dose-Response Relationship, Drug; Liver; Male; Mitolactol; Mutagenicity Tests; Mutation; Rats; Rats, Inbred Strains; Salmonella typhimurium | 1982 |
Chemotherapeutic approaches to brain tumors. Experimental observations with dianhydrogalactitol and dibromodulcitol.
Topics: Animals; Brain Neoplasms; Carmustine; Cells, Cultured; Dianhydrogalactitol; Drug Therapy, Combination; Humans; Kinetics; Mice; Mice, Inbred C57BL; Mitolactol; Neoplasms, Experimental; Rats; Rats, Inbred F344; Sugar Alcohols | 1982 |
Effect of phenobarbital on the toxicity and antitumor activity of dibromodulcitol and dianhydrogalactitol.
Topics: Animals; Antineoplastic Agents; Dianhydrogalactitol; Drug Interactions; Female; Mice; Mitolactol; Phenobarbital; Rats; Rats, Inbred Strains; Sugar Alcohols | 1982 |
Complex evaluation of the effect of some cytostatic hexitol derivatives.
Topics: Animals; Antineoplastic Agents; Dianhydrogalactitol; Drug Evaluation, Preclinical; Mice; Mitolactol; Neoplasms, Experimental; Sugar Alcohols | 1980 |